Differentiation between SSR4+ and SSR4- cells suggests that SSR4 might regulate the interactions between ESCC tumor plasma cells and TME, possibly by modulating the MIF/CD74/CXCR4 axis. The gene discussed is CXCR4; the disease is esophageal squamous cell carcinoma.